Does Rallies show Form 4 insider transactions for HQY?

Yes. Rallies tracks HQY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is HQY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HQY. It does not provide personalized investment advice.

HQY (HealthEquity, Inc) Stock Analysis - Insider Trades

HealthEquity, Inc (HQY) is a publicly traded Healthcare sector company. As of May 20, 2026, HQY trades at $87.51 with a market cap of $6.96B and a P/E ratio of 38.91. HQY moved +3.41% today. Year to date, HQY is -6.33%; over the trailing twelve months it is -13.47%. Its 52-week range spans $72.76 to $116.65. Analyst consensus is strong buy with an average price target of $114.40. Rallies surfaces HQY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading HQY stock inside the company?

Recent HQY insider activity includes Ladd Delano sold 1.50K, Rosner Elimelech sold 10.96K, Wellborn Gayle Furgurson sold 4.34K, Ladd Delano sold 1.50K, and Ladd Delano sold 1.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

HQY Key Metrics

Key financial metrics for HQY
Metric	Value
Price	$87.51
Market Cap	$6.96B
P/E Ratio	38.91
EPS	$2.21
Dividend Yield	0.00%
52-Week High	$116.65
52-Week Low	$72.76
Volume	1.08M
Avg Volume	0
Revenue (TTM)	$1.29B
Net Income	$191.83M
Gross Margin	67.72%

Recent HQY Insider Trades

Ladd Delano sold 1.50K (~$142.08K) on Dec 19, 2025.
Rosner Elimelech sold 10.96K (~$1.05M) on Dec 18, 2025.
Wellborn Gayle Furgurson sold 4.34K (~$425.33K) on Dec 12, 2025.
Ladd Delano sold 1.50K (~$156.84K) on Nov 20, 2025.
Ladd Delano sold 1.50K (~$138.10K) on Oct 20, 2025.

Latest HQY News

HealthEquity drops as custodial-cash yield outlook drives renewed rate-sensitivity worries — Apr 28, 2026
HealthEquity jumps as investors revisit raised FY2027 outlook and margin gains — Apr 27, 2026
HealthEquity jumps as year-end HSA assets hit $36.5B and outlook holds — Apr 26, 2026
HealthEquity jumps 6% as BMO upgrades to Outperform, lifts target to $105 — Apr 25, 2026
HealthEquity jumps as raised FY2027 outlook regains focus after leadership changes — Apr 24, 2026

HQY Analyst Consensus

11 analysts cover HQY: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $114.40.

Common questions about HQY

Who is trading HQY stock inside the company?: Recent HQY insider activity includes Ladd Delano sold 1.50K, Rosner Elimelech sold 10.96K, Wellborn Gayle Furgurson sold 4.34K, Ladd Delano sold 1.50K, and Ladd Delano sold 1.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for HQY?: Yes. Rallies tracks HQY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is HQY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HQY. It does not provide personalized investment advice.